Kathi Niffenegger
Equibles does not estimate personal net worth.
About Kathi Niffenegger
Earlier roles on record: CFO at Edesa Biotech, Inc. (EDSA) until July 15, 2023. Edesa Biotech, Inc. reported in an 8-K filed May 24, 2023 that Kathi Niffenegger retired as Chief Financial Officer, effective July 15, 2023. The proxy statement of Edesa Biotech, Inc. reports total compensation of $505,311 for Kathi Niffenegger in fiscal 2020, including a base salary of $234,069. Disclosed compensation is on record for 2 fiscal years.
“On May 23, 2023, Kathi Niffenegger, the Chief Financial Officer of the Company, notified the Company of her intention to retire from her position and responsibilities as Chief Financial Officer effective July 15, 2023.”
Affiliation history
-
Start not stated–2023-07-15
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Edesa Biotech, Inc. (EDSA) | Chief Financial Officer | $234,069 | $505,311 |
| 2019 | Edesa Biotech, Inc. (EDSA) | Chief Financial Officer | $63,604 | $122,354 |